Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV–Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial
Virologic suppression and CD4+ cell count recovery after initiation of raltegravir or efavirenz-containing HIV treatment regimens
Tags: AIDS, HIV, NNRTI antiretroviral, Sustiva®
BASi Method Number SAP.159
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
